ARCHIVES

FDA Says ImClone Data Insufficient To Evaluate Colorectal Cancer Drug C225.

This article is from The Cancer Letter archive.

Vol. 28 No. | March 8, 2002

Download PDF Visit The Full Archive

Related Articles

DCT Board Approves More Than $25 Million In Contract Recompetitions, Two New Contracts

February 23, 1990

ONS Opposes AMA On “Registered Care Technologist”

August 19, 1988

FDA Approves SNDA For Gardasil For Anal Cancer And Precancerous Lesions

January 28, 2011

DePinho Seeks Broad Waiver From COI Policy To Cover Financial Ties With 12 Entities

September 21, 2012

Maguire Backs Cancer Program But Insists On New Emphasis for Prevention

January 26, 1979

University of Oklahoma Wins Planning Grant; Three Mile Island Follow-Up Finds No Significant Increase In Cancer Deaths

November 2, 2002